Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 21, 2014; 20(35): 12574-12580
Published online Sep 21, 2014. doi: 10.3748/wjg.v20.i35.12574
Published online Sep 21, 2014. doi: 10.3748/wjg.v20.i35.12574
Figure 3 Results of our model to calculate the individual probability of immunosuppressive treatment depending on the identified risk factors; representation of three hypothetical patients.
Right handside: Percentage of patients with a probability to require immunosuppressive treatment (IT) no more than 20%, at least 80% and at least 90%, respectively (Patient #1: female; 19 years at diagnosis; pancolitis; hospitalisation and steroids at diagnosis, steroid-refractory; Patient #2: male; 28 years at diagnosis, left-sided colitis; hospitalisation and steroids at diagnosis; remission; Patient #3: male; 47 years at diagnosis; proctitis; no hospitalisation and no steroids at diagnosis).
- Citation: Stallmach A, Nickel L, Lehmann T, Bokemeyer B, Bürger M, Hüppe D, Kruis W, Nikolaus S, Preiss JC, Sturm A, Teich N, Schmidt C. Parameters of a severe disease course in ulcerative colitis. World J Gastroenterol 2014; 20(35): 12574-12580
- URL: https://www.wjgnet.com/1007-9327/full/v20/i35/12574.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i35.12574